Brett Chevalier is listed by Anterra Capital as Chief scientist. He did his Ph.D. at the University of Washington and his post-doctoral fellowship at MIT, worked as an academic, and then joined Flagship Ventures, where over the following 15 years he co-founded and helped launch several biotechs for human therapeutics. Anterra's site states his sector focus is biotechnology solutions for global problems in food, agriculture, and climate.
Education
Ph.D., University of Washington
Post-doctoral fellowship, MIT
Previous Experience
Academic researcher
Flagship Ventures (co-founded and helped launch several biotechs for human therapeutics over 15 years)
Career Timeline
null
Completed a Ph.D. at the University of Washington and a post-doctoral fellowship at MIT.
null
Worked as an academic before joining Flagship Ventures.
null
Co-founded and helped launch several biotechs for human therapeutics over the following 15 years.
null
Joined Anterra Capital, where the firm lists him as Chief scientist.